Where can I read HALO's latest 10-K?

HALO's latest annual report, a 10-K, was filed on Feb 17, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.

When did HALO last file an 8-K?

On Sep 30, 2026: directors or officers; compensation. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 6, 2026.

Are HALO insiders buying or selling?

Over the last 13 months insiders sold $36.0M in 32 sales and bought nothing on the open market; 125 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Posard Matthew L. (Director) sold 5,230 shares on Oct 1, 2026 for $568K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.

How many SEC filings has HALO made?

1,514 filings are on EDGAR under the registrant records that have been Halozyme Therapeutics Inc., going back to 2001; 847 of them are insider ownership forms (Forms 3, 4, 5 and 144).

Share this page

HALO

$109.86+2.73%

as of close, Oct 2, 2026

☾ AH $109.86 +2.73%

Halozyme Therapeutics Inc.Stock · Health CareNasdaq Composite 0.02%Russell 3000 0.01%Russell 1000 0.01%US Stock Market 0.01%

PeersMRNALLYUNHJNJMRKTMO

HALO SEC filings (2026)

CIK 1159036 · Biological Products, (No Diagnostic Substances) (SIC 2836) · incorporated in DE · fiscal year ends in December

1,514 filings on EDGAR since 2001 · 20 annual, 63 quarterly, 296 current · financial statements · earnings

Latest 10-K

Feb 17, 2026

fiscal year to Dec 31, 2025

Latest 10-Q

Aug 6, 2026

quarter to Jun 30, 2026

Latest 8-K

Sep 30, 2026

Directors or officers; compensation

Last earnings release

Aug 6, 2026

$2.17 vs $1.73 · ▲ 20.2%

Filings on file

1,514

since 2001, 847 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by what they covered, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

June 2026

May 2026

May 13Insider saleTorley Helen (PRESIDENT AND CEO · Director) sold 10,000 shares for $692K at $68.10–$70.81 under a 10b5-1 plan
May 12Insider saleTorley Helen (PRESIDENT AND CEO · Director) sold 20,000 shares for $1.4M at $67.85–$73.12 under a 10b5-1 plan
May 11EarningsEarnings release — EPS $1.48 vs $1.46 est. (+1.4%); revenue $376.7M (+42% y/y) 6.8%
May 11ReportQuarterly report, Q1 2026 — revenue $376.7M (+42% y/y), net income $150.0M, EPS $1.22
May 11Insider saleTorley Helen (PRESIDENT AND CEO · Director) sold 20,000 shares for $1.3M at $64.63–$66.33 under a 10b5-1 plan
May 78-K8-K · Shareholder vote results
May 1Insider saleConnaughton Bernadette (Director) sold 1,625 shares for $103K at $63.48 under a 10b5-1 plan

April 2026

Apr 308-K8-K · Directors or officers; compensation
Apr 248-K8-K · Charter, bylaws or fiscal-year change
Apr 6Insider saleTorley Helen (PRESIDENT AND CEO · Director) sold 10,000 shares for $635K at $63.14–$64.02 under a 10b5-1 plan
Apr 2Insider saleTorley Helen (PRESIDENT AND CEO · Director) sold 20,000 shares for $1.3M at $64.06–$64.89 under a 10b5-1 plan
Apr 1Insider saleTorley Helen (PRESIDENT AND CEO · Director) sold 20,000 shares for $1.3M at $65.36–$65.71 under a 10b5-1 plan

March 2026

Mar 23ProxyProxy · Annual report to shareholders
Mar 23ProxyProxy · Additional proxy materials
Mar 23ProxyProxy · Proxy statement
Mar 128-K8-K · Directors or officers; compensation
Mar 10Insider saleCaudill Cortney (SVP, CHIEF OPERATING OFFICER) sold 8,857 shares for $599K at $67.64
Mar 9Insider saleCaudill Cortney (SVP, CHIEF OPERATING OFFICER) sold 20,000 shares for $1.4M at $67.75–$68.25
Mar 4Insider saleTorley Helen (PRESIDENT AND CEO · Director) sold 10,000 shares for $702K at $69.94–$70.95 under a 10b5-1 plan
Mar 3Insider saleTorley Helen (PRESIDENT AND CEO · Director) sold 20,000 shares for $1.4M at $68.85–$69.33 under a 10b5-1 plan
Mar 2Insider saleTorley Helen (PRESIDENT AND CEO · Director) sold 20,000 shares for $1.4M at $69.20–$70.46 under a 10b5-1 plan

February 2026

January 2026

Jan 288-K8-K · Results of operations
Jan 5Insider saleConnaughton Bernadette (Director) sold 2,000 shares for $141K at $70.25 under a 10b5-1 plan

December 2025

Dec 98-K8-K · Directors or officers; compensation
Dec 88-K8-K · Directors or officers; compensation

November 2025

Nov 248-K8-K · Directors or officers; compensation
Nov 128-K8-K · Material definitive agreement; New financial obligation; Unregistered sale of equity
Nov 78-K8-K · Other events
Nov 58-K8-K · Material definitive agreement; New financial obligation; Other events
Nov 3EarningsEarnings release — EPS $1.63 vs $1.54 est. (+5.8%); revenue $354.3M (+22% y/y) 2.8%
Nov 3ReportQuarterly report, Q3 2025 — revenue $354.3M (+22% y/y), net income $175.2M, EPS $1.43

October 2025

Oct 148-K8-K · Regulation FD disclosure
Oct 68-K8-K · Directors or officers; compensation
Oct 38-K8-K · Material definitive agreement

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $36.0M in 32 sales and bought nothing on the open market; 125 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Oct 1, 2026Form 4	Posard Matthew L.DirectorSold · $568K · 5,230 sh · 10b5-1	Sold· 10b5-1 plan	5,230	$107.17–$110.04	$568K	53,609	Form 4
Sep 16, 2026Form 4	Posard Matthew L.DirectorSold · $2.0M · 18,996 sh · 10b5-1	Sold· 10b5-1 plan	18,996	$106.13–$108.99	$2.0M	58,839	Form 4
Sep 11, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $2.1M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$107.15–$107.55	$2.1M	767,780	Form 4
Sep 10, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $2.1M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$107.01–$107.58	$2.1M	767,780	Form 4
Sep 9, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $2.1M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$107.22–$108.67	$2.1M	767,780	Form 4
Aug 19, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $2.1M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$106.36–$107.77	$2.1M	767,780	Form 4
Aug 18, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $2.1M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$103.08–$104.87	$2.1M	767,780	Form 4
Aug 17, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $2.1M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$98.96–$103.48	$2.1M	767,780	Form 4
Aug 10, 2026Form 4	Connaughton BernadetteDirectorSold · $167K · 1,626 sh · 10b5-1	Sold· 10b5-1 plan	1,626	$102.80	$167K	40,418	Form 4
Jul 8, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $153K · 1,923 sh · 10b5-1	Sold· 10b5-1 plan	1,923	$79.28–$80.19	$153K	767,780	Form 4
Jul 1, 2026Form 4	Connaughton BernadetteDirectorSold · $125K · 1,625 sh · 10b5-1	Sold· 10b5-1 plan	1,625	$76.40–$77.21	$125K	42,044	Form 4
Jun 29, 2026Form 4	Krishnan MaheshDirectorSold · $548K · 7,304 sh · 10b5-1	Sold· 10b5-1 plan	7,304	$75.00	$548K	14,462	Form 4
Jun 3, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $691K · 10,000 sh · 10b5-1	Sold· 10b5-1 plan	10,000	$66.37–$69.69	$691K	767,780	Form 4
Jun 2, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.3M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$66.31–$66.75	$1.3M	767,780	Form 4
Jun 1, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.4M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$66.39–$68.35	$1.4M	767,780	Form 4
Jun 1, 2026Form 4	Connaughton BernadetteDirectorSold · $108K · 1,625 sh · 10b5-1	Sold· 10b5-1 plan	1,625	$66.21	$108K	43,669	Form 4
May 13, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $692K · 10,000 sh · 10b5-1	Sold· 10b5-1 plan	10,000	$68.10–$70.81	$692K	767,780	Form 4
May 12, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.4M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$67.85–$73.12	$1.4M	767,780	Form 4
May 11, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.3M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$64.63–$66.33	$1.3M	767,780	Form 4
May 1, 2026Form 4	Connaughton BernadetteDirectorSold · $103K · 1,625 sh · 10b5-1	Sold· 10b5-1 plan	1,625	$63.48	$103K	38,498	Form 4
Apr 6, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $635K · 10,000 sh · 10b5-1	Sold· 10b5-1 plan	10,000	$63.14–$64.02	$635K	767,780	Form 4
Apr 2, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.3M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$64.06–$64.89	$1.3M	767,780	Form 4
Apr 1, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.3M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$65.36–$65.71	$1.3M	767,780	Form 4
Mar 10, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERSold · $599K · 8,857 sh	Sold	8,857	$67.64	$599K	7,055	Form 4
Mar 9, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERSold · $1.4M · 20,000 sh	Sold	20,000	$67.75–$68.25	$1.4M	14,366	Form 4
Mar 4, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $702K · 10,000 sh · 10b5-1	Sold· 10b5-1 plan	10,000	$69.94–$70.95	$702K	767,780	Form 4
Mar 3, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.4M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$68.85–$69.33	$1.4M	767,780	Form 4
Mar 2, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.4M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$69.20–$70.46	$1.4M	767,780	Form 4
Feb 5, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $786K · 10,000 sh · 10b5-1	Sold· 10b5-1 plan	10,000	$78.38–$78.94	$786K	708,719	Form 4
Feb 4, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.5M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$76.94–$77.54	$1.5M	708,719	Form 4
Feb 3, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorSold · $1.5M · 20,000 sh · 10b5-1	Sold· 10b5-1 plan	20,000	$74.88–$76.73	$1.5M	708,719	Form 4
Jan 5, 2026Form 4	Connaughton BernadetteDirectorSold · $141K · 2,000 sh · 10b5-1	Sold· 10b5-1 plan	2,000	$70.25	$141K	40,123	Form 4

Awards, exercises, withholding and plan purchases · 125 transactions

Date	Insider	Action	Shares	Price	Value	Held after	Filing
Oct 1, 2026Form 4	Daly James MDirectorAward · Option to Purchase Common … · $0 · 1,775 sh	Award· Option to Purchase Common …	1,775	$0.00	$0	1,775	Form 4
Oct 1, 2026Form 4	Daly James MDirectorAward · Restricted Stock Units · $0 · 1,169 sh	Award· Restricted Stock Units	1,169	$0.00	$0	1,169	Form 4
Sep 11, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $368K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$18.41	$368K	787,780	Form 4
Sep 11, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $368K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$18.41	$368K	81,552	Form 4
Sep 10, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $368K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$18.41	$368K	787,780	Form 4
Sep 10, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $368K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$18.41	$368K	101,552	Form 4
Sep 9, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $368K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$18.41	$368K	787,780	Form 4
Sep 9, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $368K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$18.41	$368K	121,552	Form 4
Sep 1, 2026Form 4	Appelhans DannielleDirectorAward · Option to Purchase Common … · $0 · 1,778 sh	Award· Option to Purchase Common …	1,778	$0.00	$0	1,778	Form 4
Sep 1, 2026Form 4	Appelhans DannielleDirectorAward · Restricted Stock Units · $0 · 1,161 sh	Award· Restricted Stock Units	1,161	$0.00	$0	1,161	Form 4
Aug 19, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $368K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$18.41	$368K	787,780	Form 4
Aug 19, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $368K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$18.41	$368K	141,552	Form 4
Aug 18, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $368K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$18.41	$368K	787,780	Form 4
Aug 18, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $368K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$18.41	$368K	161,552	Form 4
Aug 17, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $368K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$18.41	$368K	787,780	Form 4
Aug 17, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $368K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$18.41	$368K	181,552	Form 4
Jul 8, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $23K · 1,923 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	1,923	$12.07	$23K	769,703	Form 4
Jul 8, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $23K · 1,923 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	1,923	$12.07	$23K	0	Form 4
Jul 1, 2026Form 4	Snellgrove DarrenSVP, Chief Financial OfficerAward · Option to Purchase Common … · $0 · 127,432 sh	Award· Option to Purchase Common …	127,432	$0.00	$0	127,432	Form 4
Jul 1, 2026Form 4	Snellgrove DarrenSVP, Chief Financial OfficerAward · Restricted Stock Units · $0 · 41,554 sh	Award· Restricted Stock Units	41,554	$0.00	$0	41,554	Form 4
Jul 1, 2026Form 4	RAMSAY DAVID AEVP, PRESIDENT, DRUG DELIVERYAward · Option to Purchase Common … · $0 · 39,823 sh	Award· Option to Purchase Common …	39,823	$0.00	$0	39,823	Form 4
Jul 1, 2026Form 4	RAMSAY DAVID AEVP, PRESIDENT, DRUG DELIVERYAward · Restricted Stock Units · $0 · 16,232 sh	Award· Restricted Stock Units	16,232	$0.00	$0	16,232	Form 4
Jun 30, 2026Form 4	RAMSAY DAVID AEVP, PRESIDENT, DRUG DELIVERYTax withholding · $423K · 5,408 sh	Tax withholding	5,408	$78.27	$423K	4,592	Form 4
Jun 30, 2026Form 4	RAMSAY DAVID AEVP, PRESIDENT, DRUG DELIVERYExercise or conversion · $0 · 10,000 sh	Exercise or conversion	10,000	$0.00	$0	10,000	Form 4
Jun 30, 2026Form 4	RAMSAY DAVID AEVP, PRESIDENT, DRUG DELIVERYExercise or conversion · Restricted Stock Units · $0 · 10,000 sh	Exercise or conversion· Restricted Stock Units	10,000	$0.00	$0	0	Form 4
Jun 29, 2026Form 4	Krishnan MaheshDirectorExercise or conversion · $281K · 7,304 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	7,304	$38.46	$281K	21,766	Form 4
Jun 29, 2026Form 4	Krishnan MaheshDirectorExercise or conversion · Option to Purchase Common … · $0 · 7,304 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	7,304	$0.00	$0	1,500	Form 4
Jun 12, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERTax withholding · $189K · 2,715 sh	Tax withholding	2,715	$69.50	$189K	49,929	Form 4
Jun 12, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · $0 · 5,034 sh	Exercise or conversion	5,034	$0.00	$0	52,644	Form 4
Jun 12, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · Restricted Stock Units · $0 · 5,034 sh	Exercise or conversion· Restricted Stock Units	5,034	$0.00	$0	10,068	Form 4
Jun 3, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $121K · 10,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	10,000	$12.07	$121K	777,780	Form 4
Jun 3, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $121K · 10,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	10,000	$12.07	$121K	1,923	Form 4
Jun 2, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	787,780	Form 4
Jun 2, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	11,923	Form 4
Jun 1, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	787,780	Form 4
Jun 1, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	31,923	Form 4
May 13, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $121K · 10,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	10,000	$12.07	$121K	777,780	Form 4
May 13, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $121K · 10,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	10,000	$12.07	$121K	51,923	Form 4
May 12, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	787,780	Form 4
May 12, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	61,923	Form 4
May 11, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	787,780	Form 4
May 11, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	81,923	Form 4
May 5, 2026Form 4	Connaughton BernadetteDirectorAward · $0 · 6,796 sh	Award	6,796	$0.00	$0	45,294	Form 4
May 5, 2026Form 4	Connaughton BernadetteDirectorAward · Option to Purchase Common … · $0 · 6,040 sh	Award· Option to Purchase Common …	6,040	$0.00	$0	6,040	Form 4
May 5, 2026Form 4	DUNCAN BARBARA GAYLEDirectorAward · Option to Purchase Common … · $0 · 6,040 sh	Award· Option to Purchase Common …	6,040	$0.00	$0	6,040	Form 4
May 5, 2026Form 4	Henderson Jeffrey WilliamDirectorAward · Option to Purchase Common … · $0 · 6,040 sh	Award· Option to Purchase Common …	6,040	$0.00	$0	6,040	Form 4
May 5, 2026Form 4	Lang James PaulDirectorAward · Option to Purchase Common … · $0 · 6,040 sh	Award· Option to Purchase Common …	6,040	$0.00	$0	6,040	Form 4
May 5, 2026Form 4	Krishnan MaheshDirectorAward · Option to Purchase Common … · $0 · 6,040 sh	Award· Option to Purchase Common …	6,040	$0.00	$0	6,040	Form 4
May 5, 2026Form 4	Posard Matthew L.DirectorAward · Option to Purchase Common … · $0 · 6,040 sh	Award· Option to Purchase Common …	6,040	$0.00	$0	6,040	Form 4
May 5, 2026Form 4	DUNCAN BARBARA GAYLEDirectorAward · $0 · 3,796 sh	Award	3,796	$0.00	$0	23,715	Form 4
May 5, 2026Form 4	Henderson Jeffrey WilliamDirectorAward · $0 · 3,796 sh	Award	3,796	$0.00	$0	36,572	Form 4
May 5, 2026Form 4	Lang James PaulDirectorAward · $0 · 3,796 sh	Award	3,796	$0.00	$0	4,685	Form 4
May 5, 2026Form 4	Krishnan MaheshDirectorAward · $0 · 3,796 sh	Award	3,796	$0.00	$0	14,462	Form 4
May 5, 2026Form 4	Posard Matthew L.DirectorAward · $0 · 3,796 sh	Award	3,796	$0.00	$0	77,835	Form 4
Apr 6, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $121K · 10,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	10,000	$12.07	$121K	777,780	Form 4
Apr 6, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $121K · 10,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	10,000	$12.07	$121K	101,923	Form 4
Apr 2, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	787,780	Form 4
Apr 2, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	111,923	Form 4
Apr 1, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	787,780	Form 4
Apr 1, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	131,923	Form 4
Apr 1, 2026Form 4	RAMSAY DAVID AInterim CFOAward · Restricted Stock Units · $0 · 10,000 sh	Award· Restricted Stock Units	10,000	$0.00	$0	10,000	Form 4
Mar 10, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERExercise or conversion · $52K · 1,546 sh	Exercise or conversion	1,546	$33.51	$52K	15,912	Form 4
Mar 10, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERExercise or conversion · Option to Purchase Common … · $52K · 1,546 sh	Exercise or conversion· Option to Purchase Common …	1,546	$33.51	$52K	67,678	Form 4
Mar 9, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERExercise or conversion · $670K · 20,000 sh	Exercise or conversion	20,000	$33.51	$670K	34,366	Form 4
Mar 9, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERExercise or conversion · Option to Purchase Common … · $670K · 20,000 sh	Exercise or conversion· Option to Purchase Common …	20,000	$33.51	$670K	69,224	Form 4
Mar 4, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $121K · 10,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	10,000	$12.07	$121K	777,780	Form 4
Mar 4, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $121K · 10,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	10,000	$12.07	$121K	151,923	Form 4
Mar 3, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	787,780	Form 4
Mar 3, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	161,923	Form 4
Mar 2, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	787,780	Form 4
Mar 2, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	181,923	Form 4
Feb 23, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorTax withholding · $855K · 12,104 sh	Tax withholding	12,104	$70.64	$855K	767,780	Form 4
Feb 23, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERTax withholding · $267K · 3,782 sh	Tax withholding	3,782	$70.64	$267K	47,610	Form 4
Feb 23, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERTax withholding · $255K · 3,608 sh	Tax withholding	3,608	$70.64	$255K	38,494	Form 4
Feb 23, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $0 · 22,436 sh	Exercise or conversion	22,436	$0.00	$0	779,884	Form 4
Feb 23, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Restricted Stock Units · $0 · 22,436 sh	Exercise or conversion· Restricted Stock Units	22,436	$0.00	$0	44,872	Form 4
Feb 23, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · $0 · 7,011 sh	Exercise or conversion	7,011	$0.00	$0	51,392	Form 4
Feb 23, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · Restricted Stock Units · $0 · 7,011 sh	Exercise or conversion· Restricted Stock Units	7,011	$0.00	$0	14,022	Form 4
Feb 23, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERExercise or conversion · $0 · 6,688 sh	Exercise or conversion	6,688	$0.00	$0	42,102	Form 4
Feb 23, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERExercise or conversion · Performance Stock Units · $0 · 6,688 sh	Exercise or conversion· Performance Stock Units	6,688	$0.00	$0	36,357	Form 4
Feb 20, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorTax withholding · $642K · 9,040 sh	Tax withholding	9,040	$70.98	$642K	757,448	Form 4
Feb 20, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERTax withholding · $204K · 2,876 sh	Tax withholding	2,876	$70.98	$204K	35,414	Form 4
Feb 20, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERTax withholding · $204K · 2,876 sh	Tax withholding	2,876	$70.98	$204K	44,381	Form 4
Feb 20, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERTax withholding · $74K · 1,037 sh	Tax withholding	1,037	$70.98	$74K	14,366	Form 4
Feb 20, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $0 · 16,757 sh	Exercise or conversion	16,757	$0.00	$0	766,488	Form 4
Feb 20, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Restricted Stock Units · $0 · 16,757 sh	Exercise or conversion· Restricted Stock Units	16,757	$0.00	$0	50,270	Form 4
Feb 20, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERExercise or conversion · $0 · 5,332 sh	Exercise or conversion	5,332	$0.00	$0	38,290	Form 4
Feb 20, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERExercise or conversion · Restricted Stock Units · $0 · 5,332 sh	Exercise or conversion· Restricted Stock Units	5,332	$0.00	$0	15,995	Form 4
Feb 20, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · $0 · 5,332 sh	Exercise or conversion	5,332	$0.00	$0	47,257	Form 4
Feb 20, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · Restricted Stock Units · $0 · 5,332 sh	Exercise or conversion· Restricted Stock Units	5,332	$0.00	$0	15,995	Form 4
Feb 20, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERExercise or conversion · $0 · 2,666 sh	Exercise or conversion	2,666	$0.00	$0	15,403	Form 4
Feb 20, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERExercise or conversion · Restricted Stock Units · $0 · 2,666 sh	Exercise or conversion· Restricted Stock Units	2,666	$0.00	$0	7,998	Form 4
Feb 16, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorTax withholding · $3.8M · 48,043 sh	Tax withholding	48,043	$79.44	$3.8M	749,731	Form 4
Feb 16, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERTax withholding · $1.0M · 12,894 sh	Tax withholding	12,894	$79.44	$1.0M	32,958	Form 4
Feb 16, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERTax withholding · $720K · 9,068 sh	Tax withholding	9,068	$79.44	$720K	41,925	Form 4
Feb 16, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $0 · 89,055 sh	Exercise or conversion	89,055	$0.00	$0	777,336	Form 4
Feb 16, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Performance Stock Units · $0 · 51,171 sh	Exercise or conversion· Performance Stock Units	51,171	$0.00	$0	0	Form 4
Feb 16, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Restricted Stock Units · $0 · 37,884 sh	Exercise or conversion· Restricted Stock Units	37,884	$0.00	$0	16,874	Form 4
Feb 16, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERExercise or conversion · $0 · 23,773 sh	Exercise or conversion	23,773	$0.00	$0	40,231	Form 4
Feb 16, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · $0 · 16,812 sh	Exercise or conversion	16,812	$0.00	$0	48,406	Form 4
Feb 16, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERExercise or conversion · Performance Stock Units · $0 · 13,351 sh	Exercise or conversion· Performance Stock Units	13,351	$0.00	$0	0	Form 4
Feb 16, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · Performance Stock Units · $0 · 12,016 sh	Exercise or conversion· Performance Stock Units	12,016	$0.00	$0	0	Form 4
Feb 16, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERExercise or conversion · Restricted Stock Units · $0 · 10,422 sh	Exercise or conversion· Restricted Stock Units	10,422	$0.00	$0	5,329	Form 4
Feb 16, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · Restricted Stock Units · $0 · 4,796 sh	Exercise or conversion· Restricted Stock Units	4,796	$0.00	$0	4,796	Form 4
Feb 9, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorAward · Performance Stock Units · $0 · 137,506 sh	Award· Performance Stock Units	137,506	$0.00	$0	92,714	Form 4
Feb 9, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorAward · Option to Purchase Common … · $0 · 53,847 sh	Award· Option to Purchase Common …	53,847	$0.00	$0	53,847	Form 4
Feb 9, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorAward · Restricted Stock Units · $0 · 50,013 sh	Award· Restricted Stock Units	50,013	$0.00	$0	50,013	Form 4
Feb 9, 2026Form 4	LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICERAward · Performance Stock Units · $0 · 42,117 sh	Award· Performance Stock Units	42,117	$0.00	$0	29,502	Form 4
Feb 9, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERAward · Performance Stock Units · $0 · 41,961 sh	Award· Performance Stock Units	41,961	$0.00	$0	29,502	Form 4
Feb 9, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERAward · Option to Purchase Common … · $0 · 18,730 sh	Award· Option to Purchase Common …	18,730	$0.00	$0	18,730	Form 4
Feb 9, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERAward · Restricted Stock Units · $0 · 17,396 sh	Award· Restricted Stock Units	17,396	$0.00	$0	17,396	Form 4
Feb 9, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERAward · Performance Stock Units · $0 · 17,154 sh	Award· Performance Stock Units	17,154	$0.00	$0	14,751	Form 4
Feb 9, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERAward · Option to Purchase Common … · $0 · 14,047 sh	Award· Option to Purchase Common …	14,047	$0.00	$0	14,047	Form 4
Feb 9, 2026Form 4	Caudill CortneySVP, CHIEF OPERATING OFFICERAward · Restricted Stock Units · $0 · 13,047 sh	Award· Restricted Stock Units	13,047	$0.00	$0	13,047	Form 4
Feb 5, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $121K · 10,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	10,000	$12.07	$121K	718,719	Form 4
Feb 5, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $121K · 10,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	10,000	$12.07	$121K	201,923	Form 4
Feb 4, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	728,719	Form 4
Feb 4, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	211,923	Form 4
Feb 3, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · $241K · 20,000 sh · 10b5-1	Exercise or conversion· 10b5-1 plan	20,000	$12.07	$241K	728,719	Form 4
Feb 3, 2026Form 4	Torley HelenPRESIDENT AND CEO · DirectorExercise or conversion · Option to Purchase Common … · $241K · 20,000 sh · 10b5-1	Exercise or conversion· Option to Purchase Common …· 10b5-1 plan	20,000	$12.07	$241K	231,923	Form 4
Jan 3, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERTax withholding · $298K · 4,243 sh	Tax withholding	4,243	$70.31	$298K	34,181	Form 4
Jan 3, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · $0 · 7,611 sh	Exercise or conversion	7,611	$0.00	$0	38,424	Form 4
Jan 3, 2026Form 4	Snyder Mark HowardSVP, CHIEF LEGAL OFFICERExercise or conversion · Restricted Stock Units · $0 · 7,611 sh	Exercise or conversion· Restricted Stock Units	7,611	$0.00	$0	0	Form 4
Jan 2, 2026Form 4	Lang James PaulDirectorAward · Option to Purchase Common … · $0 · 1,342 sh	Award· Option to Purchase Common …	1,342	$0.00	$0	1,342	Form 4
Jan 2, 2026Form 4	Lang James PaulDirectorAward · Restricted Stock Units · $0 · 889 sh	Award· Restricted Stock Units	889	$0.00	$0	889	Form 4

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K is described by its items. A form opens the document on EDGAR, or the filing’s index where it furnishes exhibits (an earnings release is the 8-K’s Exhibit 99.1).

2026 · 20 filings

Filed	Form	What it is	Period
Sep 30, 20268-K	8-K	Directors or officers; compensation	Sep 28, 2026
Sep 22, 20268-K	8-K	Material definitive agreement; New financial obligation; Unregistered sale of equity	Sep 22, 2026
Sep 18, 20268-K	8-K	Other events	Sep 17, 2026
Sep 16, 20268-K	8-K	Other events	Sep 16, 2026
Aug 18, 20268-K	8-K	Directors or officers; compensation	Aug 14, 2026
Aug 6, 202610-Q	10-Q	Quarterly report, Q2 2026 — revenue $481.0M (+48% y/y), net income $229.9M, EPS $1.90	Jun 30, 2026
Aug 6, 20268-K	8-K	Earnings release — EPS $2.17 vs $1.73 est. (+25.4%); revenue $481.0M (+48% y/y) 20.2%	Aug 6, 2026
Jul 2, 20268-K	8-K	Directors or officers; compensation	Jun 30, 2026
May 11, 202610-Q	10-Q	Quarterly report, Q1 2026 — revenue $376.7M (+42% y/y), net income $150.0M, EPS $1.22	Mar 31, 2026
May 11, 20268-K	8-K	Earnings release — EPS $1.48 vs $1.46 est. (+1.4%); revenue $376.7M (+42% y/y) 6.8%	May 11, 2026
May 7, 20268-K	8-K	Shareholder vote results	May 5, 2026
Apr 30, 20268-K	8-K	Directors or officers; compensation	Apr 30, 2026
Apr 24, 20268-K	8-K	Charter, bylaws or fiscal-year change	Apr 22, 2026
Mar 23, 2026ARS	ARS	Annual report to shareholders	Dec 31, 2025
Mar 23, 2026DEFA14A	DEFA14A	Additional proxy materials	—
Mar 23, 2026DEF 14A	DEF 14A	Proxy statement	Dec 31, 2025
Mar 12, 20268-K	8-K	Directors or officers; compensation	Mar 12, 2026
Feb 17, 202610-K	10-K	Annual report, FY2025 — revenue $1.40B (+38% y/y), net income $316.9M, EPS $2.56	Dec 31, 2025
Feb 17, 20268-K	8-K	Earnings release — EPS −$0.35 vs $2.07 est. (−116.9%); revenue $451.8M (+52% y/y) 9.0%	Feb 17, 2026
Jan 28, 20268-K	8-K	Results of operations	Jan 28, 2026

2025 · 25 filings

Filed	Form	What it is	Period
Dec 9, 20258-K	8-K	Directors or officers; compensation	Dec 4, 2025
Dec 8, 20258-K	8-K	Directors or officers; compensation	Dec 4, 2025
Nov 24, 20258-K	8-K	Directors or officers; compensation	Nov 18, 2025
Nov 12, 20258-K	8-K	Material definitive agreement; New financial obligation; Unregistered sale of equity	Nov 6, 2025
Nov 7, 20258-K	8-K	Other events	Nov 6, 2025
Nov 5, 20258-K	8-K	Material definitive agreement; New financial obligation; Other events	Nov 5, 2025
Nov 3, 202510-Q	10-Q	Quarterly report, Q3 2025 — revenue $354.3M (+22% y/y), net income $175.2M, EPS $1.43	Sep 30, 2025
Nov 3, 20258-K	8-K	Earnings release — EPS $1.63 vs $1.54 est. (+5.8%); revenue $354.3M (+22% y/y) 2.8%	Nov 3, 2025
Oct 14, 20258-K	8-K	Regulation FD disclosure	Oct 14, 2025
Oct 6, 20258-K	8-K	Directors or officers; compensation	Oct 1, 2025
Oct 3, 20258-K	8-K	Material definitive agreement	Sep 30, 2025
Oct 1, 20258-K	8-K	Regulation FD disclosure	Sep 30, 2025
Aug 5, 202510-Q	10-Q	Quarterly report, Q2 2025 — revenue $325.7M (+41% y/y), net income $165.2M, EPS $1.33	Jun 30, 2025
Aug 5, 20258-K	8-K	Results of operations	Aug 5, 2025
May 6, 202510-Q	10-Q	Quarterly report, Q1 2025 — revenue $264.9M (+35% y/y), net income $118.1M, EPS $0.93	Mar 31, 2025
May 6, 20258-K	8-K	Results of operations	May 6, 2025
May 2, 20258-K	8-K	Shareholder vote results	May 1, 2025
Mar 21, 20258-K	8-K	Directors or officers; compensation	Mar 17, 2025
Mar 18, 2025ARS	ARS	Annual report to shareholders	Dec 31, 2024
Mar 18, 2025DEFA14A	DEFA14A	Additional proxy materials	—
Mar 18, 2025DEF 14A	DEF 14A	Proxy statement	Dec 31, 2024
Feb 18, 202510-K	10-K	Annual report, FY2024 — revenue $1.02B (+22% y/y), net income $444.1M, EPS $3.43	Dec 31, 2024
Feb 18, 20258-K	8-K	Results of operations	Feb 18, 2025
Feb 13, 20258-K	8-K	Directors or officers; compensation	Feb 11, 2025
Jan 8, 20258-K	8-K	Results of operations	Jan 8, 2025

2024 · 14 filings

Filed	Form	What it is	Period
Oct 31, 202410-Q	10-Q	Quarterly report, Q3 2024 — revenue $290.1M (+34% y/y), net income $137.0M, EPS $1.05	Sep 30, 2024
Oct 31, 20248-K	8-K	Results of operations	Oct 31, 2024
Aug 6, 202410-Q	10-Q	Quarterly report, Q2 2024 — revenue $231.4M (+5% y/y), net income $93.2M, EPS $0.72	Jun 30, 2024
Aug 6, 20248-K	8-K	Results of operations	Aug 6, 2024
May 7, 202410-Q	10-Q	Quarterly report, Q1 2024 — revenue $195.9M (+21% y/y), net income $76.8M, EPS $0.60	Mar 31, 2024
May 7, 20248-K	8-K	Results of operations	May 7, 2024
Apr 26, 20248-K	8-K	Shareholder vote results	Apr 25, 2024
Mar 15, 2024ARS	ARS	Annual report to shareholders	Dec 31, 2023
Mar 15, 2024DEFA14A	DEFA14A	Additional proxy materials	—
Mar 15, 2024DEF 14A	DEF 14A	Proxy statement	Dec 31, 2023
Mar 4, 2024PRE 14A	PRE 14A	Preliminary proxy statement	Dec 31, 2023
Feb 20, 202410-K	10-K	Annual report, FY2023 — revenue $829.3M (+26% y/y), net income $281.6M, EPS $2.10	Dec 31, 2023
Feb 20, 20248-K	8-K	Results of operations	Feb 20, 2024
Jan 17, 20248-K	8-K	Results of operations	Jan 17, 2024

2023 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Filed	Form	What it is	Period
Nov 6, 202310-Q	10-Q	Quarterly report, Q3 2023 — revenue $216.0M (+3% y/y), net income $81.8M, EPS $0.61	Sep 30, 2023
Aug 8, 202310-Q	10-Q	Quarterly report, Q2 2023 — revenue $221.0M (+45% y/y), net income $74.8M, EPS $0.56	Jun 30, 2023
May 9, 202310-Q	10-Q	Quarterly report, Q1 2023 — revenue $162.1M (+38% y/y), net income $39.6M, EPS $0.29	Mar 31, 2023
Mar 24, 2023ARS	ARS	Annual report to shareholders	Dec 31, 2022
Mar 24, 2023DEFA14A	DEFA14A	Additional proxy materials	—
Mar 24, 2023DEF 14A	DEF 14A	Proxy statement	—
Feb 21, 202310-K	10-K	Annual report, FY2022 — revenue $660.1M (+49% y/y), net income $202.1M, EPS $1.44	Dec 31, 2022

11 current reports (8-K) not listed; the year is on EDGAR.

2022 · 23 filings — 15 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms

Filed	Form	What it is	Period
Nov 8, 202210-Q	10-Q	Quarterly report, Q3 2022 — revenue $209.0M (+80% y/y), net income $61.6M, EPS $0.44	Sep 30, 2022
Aug 9, 202210-Q	10-Q	Quarterly report, Q2 2022 — revenue $152.4M (+12% y/y), net income $22.7M, EPS $0.16	Jun 30, 2022
May 10, 202210-Q	10-Q	Quarterly report, Q1 2022 — revenue $117.3M (+32% y/y), net income $60.1M, EPS $0.43	Mar 31, 2022
Apr 18, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2022DEFA14A	DEFA14A	Additional proxy materials	—
Mar 25, 2022DEF 14A	DEF 14A	Proxy statement	Dec 31, 2021
Feb 22, 202210-K	10-K	Annual report, FY2021 — revenue $443.3M (+66% y/y), net income $402.7M, EPS $2.74	Dec 31, 2021

16 current reports (8-K) not listed; the year is on EDGAR.

2021 · 22 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Filed	Form	What it is	Period
Nov 2, 202110-Q	10-Q	Quarterly report, Q3 2021 — revenue $115.8M (+77% y/y), net income $216.6M, EPS $1.48	Sep 30, 2021
Aug 9, 202110-Q	10-Q	Quarterly report, Q2 2021 — revenue $136.5M (+147% y/y), net income $91.5M, EPS $0.62	Jun 30, 2021
May 10, 202110-Q	10-Q	Quarterly report, Q1 2021 — revenue $89.0M (+251% y/y), net income $27.9M, EPS $0.19	Mar 31, 2021
Mar 26, 2021DEFA14A	DEFA14A	Additional proxy materials	—
Mar 26, 2021DEF 14A	DEF 14A	Proxy statement	Dec 31, 2020
Feb 23, 202110-K	10-K	Annual report, FY2020 — revenue $267.6M (+37% y/y), net income $129.1M, EPS $0.91	Dec 31, 2020

16 current reports (8-K) not listed; the year is on EDGAR.

2020 · 15 filings — 8 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms

Filed	Form	What it is	Period
Nov 2, 202010-Q	10-Q	Quarterly report, Q3 2020 — revenue $65.3M (+41% y/y), net income $36.2M, EPS $0.25	Sep 30, 2020
Aug 10, 202010-Q	10-Q	Quarterly report, Q2 2020 — revenue $55.2M (+41% y/y), net income $25.8M, EPS $0.19	Jun 30, 2020
May 11, 202010-Q	10-Q	Quarterly report, Q1 2020 — revenue $25.4M (−55% y/y), net income −$6.1M, EPS −$0.04	Mar 31, 2020
Apr 3, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Mar 20, 2020DEFA14A	DEFA14A	Additional proxy materials	—
Mar 20, 2020DEF 14A	DEF 14A	Proxy statement	Dec 31, 2019
Feb 24, 202010-K	10-K	Annual report, FY2019 — revenue $196.0M (+29% y/y), net income −$72.2M, EPS −$0.50	Dec 31, 2019

8 current reports (8-K) not listed; the year is on EDGAR.

2019 · 20 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms

Filed	Form	What it is	Period
Nov 12, 201910-Q	10-Q	Quarterly report, Q3 2019 — revenue $46.2M (+81% y/y), net income −$25.0M, EPS −$0.17	Sep 30, 2019
Aug 6, 201910-Q	10-Q	Quarterly report, Q2 2019 — revenue $39.1M (+11% y/y), net income −$14.6M, EPS −$0.10	Jun 30, 2019
May 7, 201910-Q	10-Q	Quarterly report, Q1 2019 — revenue $56.9M (+84% y/y), net income $1.8M, EPS $0.01	Mar 31, 2019
Mar 22, 2019DEFA14A	DEFA14A	Additional proxy materials	—
Mar 22, 2019DEF 14A	DEF 14A	Proxy statement	Dec 31, 2018
Mar 1, 2019PRE 14A	PRE 14A	Preliminary proxy statement	Dec 31, 2018
Feb 21, 201910-K	10-K	Annual report, FY2018 — revenue $151.9M (−52% y/y), net income −$80.3M, EPS −$0.56	Dec 31, 2018

13 current reports (8-K) not listed; the year is on EDGAR.

2018 · 21 filings — 13 × 8-K, 3 × 10-Q, 3 × DEFA14A and 2 other forms

Filed	Form	What it is	Period
Nov 6, 201810-Q	10-Q	Quarterly report, Q3 2018 — revenue $25.6M (−60% y/y), net income −$27.9M, EPS −$0.19	Sep 30, 2018
Aug 7, 201810-Q	10-Q	Quarterly report, Q2 2018 — revenue $35.2M (+4% y/y), net income −$22.9M, EPS −$0.16	Jun 30, 2018
May 10, 201810-Q	10-Q	Quarterly report, Q1 2018 — revenue $30.9M (+4% y/y), net income −$27.5M, EPS −$0.19	Mar 31, 2018
Apr 6, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Apr 3, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Mar 22, 2018DEFA14A	DEFA14A	Additional proxy materials	—
Mar 22, 2018DEF 14A	DEF 14A	Proxy statement	Dec 31, 2017
Feb 20, 201810-K	10-K	Annual report, FY2017 — revenue $316.6M (+116% y/y), net income $63.0M, EPS $0.45	Dec 31, 2017

13 current reports (8-K) not listed; the year is on EDGAR.

2017 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Filed	Form	What it is	Period
Nov 7, 201710-Q	10-Q	Quarterly report, Q3 2017 — revenue $63.7M (+100% y/y), net income $2.7M, EPS $20.00	Sep 30, 2017
Aug 8, 201710-Q	10-Q	Quarterly report, Q2 2017 — revenue $33.8M (+1% y/y), net income −$30.8M, EPS −$230.00	Jun 30, 2017
May 9, 201710-Q	10-Q	Quarterly report, Q1 2017 — revenue $29.6M (−30% y/y), net income −$32.9M, EPS −$260.00	Mar 31, 2017
Mar 24, 2017DEFA14A	DEFA14A	Additional proxy materials	—
Mar 24, 2017DEF 14A	DEF 14A	Proxy statement	Dec 31, 2016
Feb 28, 201710-K	10-K	Annual report, FY2016 — revenue $146.7M (+9% y/y), net income −$103.0M, EPS −$0.81	Dec 31, 2016

12 current reports (8-K) not listed; the year is on EDGAR.

2016 · 19 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2015 · 18 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2014 · 15 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2013 · 19 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms

Counted, not listed; the year is on EDGAR.

2012 · 13 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2011 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2010 · 19 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2009 · 16 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form

Counted, not listed; the year is on EDGAR.

2008 · 17 filings — 11 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms

Counted, not listed; the year is on EDGAR.

2007 · 24 filings — 16 × 8-K, 3 × 10-Q, 2 × DEF 14A and 3 other forms

Counted, not listed; the year is on EDGAR.

2006 · 23 filings — 17 × 8-K, 3 × 10-Q, 1 × 8-K/A and 2 other forms

Counted, not listed; the year is on EDGAR.

2005 · 21 filings — 20 × 8-K, 1 × DEF 14A

Counted, not listed; the year is on EDGAR.

2004 · 13 filings — 12 × 8-K, 1 × 8-K/A

Counted, not listed; the year is on EDGAR.

2003 · 1 filing — 1 × 8-K

Counted, not listed; the year is on EDGAR.

2002 · 1 filing — 1 × 8-K

Counted, not listed; the year is on EDGAR.

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 62 filings — 43 × 4, 12 × 144, 5 × 3 and 2 other forms

Filed	Form	What it is	Period
Oct 2, 20264	4	Insider transaction (Form 4)	Oct 1, 2026
Oct 2, 20263	3	Initial insider holdings (Form 3)	Sep 28, 2026
Oct 2, 20264	4	Insider transaction (Form 4)	Oct 1, 2026
Sep 17, 20264	4	Insider transaction (Form 4)	Sep 16, 2026
Sep 16, 2026144	144	Notice of proposed sale (Form 144)	—
Sep 11, 20264	4	Insider transaction (Form 4)	Sep 9, 2026
Sep 2, 20264	4	Insider transaction (Form 4)	Sep 1, 2026
Aug 21, 20263	3	Initial insider holdings (Form 3)	Aug 14, 2026
Aug 19, 20264	4	Insider transaction (Form 4)	Aug 17, 2026
Aug 17, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 11, 2026144	144	Notice of proposed sale (Form 144)	—
Aug 11, 20264	4	Insider transaction (Form 4)	Aug 10, 2026
Aug 10, 2026144	144	Notice of proposed sale (Form 144)	—
Jul 9, 20264	4	Insider transaction (Form 4)	Jul 8, 2026
Jul 2, 20264	4	Insider transaction (Form 4)	Jun 30, 2026
Jul 2, 20264	4	Insider transaction (Form 4)	Jul 1, 2026
Jul 2, 20264	4	Insider transaction (Form 4)	Jul 1, 2026
Jun 30, 20264	4	Insider transaction (Form 4)	Jun 29, 2026
Jun 29, 2026144	144	Notice of proposed sale (Form 144)	—
Jun 15, 20264	4	Insider transaction (Form 4)	Jun 12, 2026
Jun 9, 20263	3	Initial insider holdings (Form 3)	Jun 8, 2026
Jun 3, 20264	4	Insider transaction (Form 4)	Jun 1, 2026
Jun 2, 20264	4	Insider transaction (Form 4)	Jun 1, 2026
May 15, 2026144	144	Notice of proposed sale (Form 144)	—
May 13, 20264	4	Insider transaction (Form 4)	May 11, 2026

The newest 25 of 62 shown; the full year is on EDGAR.

2025 · 58 filings — 46 × 4, 7 × 144, 2 × SCHEDULE 13G/A and 3 other forms

Filed	Form	What it is	Period
Dec 19, 20254	4	Insider transaction (Form 4)	Nov 1, 2025
Dec 11, 20254	4	Insider transaction (Form 4)	Dec 9, 2025
Dec 1, 20254	4	Insider transaction (Form 4)	Dec 1, 2025
Dec 1, 20254	4	Insider transaction (Form 4)	Nov 26, 2025
Nov 18, 2025S-8	S-8	Employee stock plan registration	—
Nov 12, 20254	4	Insider transaction (Form 4)	Nov 10, 2025
Nov 12, 20254	4	Insider transaction (Form 4)	Nov 10, 2025
Oct 6, 20254	4	Insider transaction (Form 4)	Oct 3, 2025
Oct 6, 20253	3	Initial insider holdings (Form 3)	Oct 1, 2025
Oct 3, 20254	4	Insider transaction (Form 4)	Oct 1, 2025
Oct 1, 20254	4	Insider transaction (Form 4)	Oct 1, 2025
Oct 1, 2025144	144	Notice of proposed sale (Form 144)	—
Sep 23, 20254	4	Insider transaction (Form 4)	Sep 22, 2025
Sep 11, 20254	4	Insider transaction (Form 4)	Sep 10, 2025
Sep 10, 2025144	144	Notice of proposed sale (Form 144)	—
Sep 4, 20254	4	Insider transaction (Form 4)	Sep 2, 2025
Sep 2, 20254	4	Insider transaction (Form 4)	Sep 2, 2025
Sep 2, 2025144	144	Notice of proposed sale (Form 144)	—
Aug 13, 20254	4	Insider transaction (Form 4)	Aug 11, 2025
Jul 17, 2025SCHEDULE 13G/A	SCHEDULE 13G/A	Other filings	—
Jul 10, 20254	4	Insider transaction (Form 4)	Jul 8, 2025
Jun 24, 20254	4	Insider transaction (Form 4)	Jun 20, 2025
Jun 20, 2025144	144	Notice of proposed sale (Form 144)	—
Jun 13, 20254	4	Insider transaction (Form 4)	Jun 12, 2025
May 13, 2025SCHEDULE 13G	SCHEDULE 13G	Other filings	—

The newest 25 of 58 shown; the full year is on EDGAR.

2024 · 88 filings — 45 × 4, 36 × 144, 5 × SC 13G/A and 2 other forms

Filed	Form	What it is	Period
Dec 3, 20244	4	Insider transaction (Form 4)	Nov 29, 2024
Dec 3, 20244	4	Insider transaction (Form 4)	Nov 29, 2024
Nov 12, 2024SC 13G/A	SC 13G/A	Passive holder above 5% (Schedule 13G), amended	—
Oct 17, 2024SC 13G	SC 13G	Passive holder above 5% (Schedule 13G)	—
Oct 16, 20244	4	Insider transaction (Form 4)	Oct 15, 2024
Oct 16, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 15, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 9, 20244	4	Insider transaction (Form 4)	Oct 8, 2024
Oct 9, 2024144	144	Notice of proposed sale (Form 144)	—
Oct 8, 2024144	144	Notice of proposed sale (Form 144)	—
Sep 26, 20244	4	Insider transaction (Form 4)	Sep 24, 2024
Sep 26, 2024144	144	Notice of proposed sale (Form 144)	—
Sep 25, 2024144	144	Notice of proposed sale (Form 144)	—
Sep 24, 2024144	144	Notice of proposed sale (Form 144)	—
Sep 18, 20244	4	Insider transaction (Form 4)	Sep 17, 2024
Sep 18, 2024144	144	Notice of proposed sale (Form 144)	—
Sep 17, 2024144	144	Notice of proposed sale (Form 144)	—
Sep 12, 20244	4	Insider transaction (Form 4)	Sep 10, 2024
Sep 12, 2024144	144	Notice of proposed sale (Form 144)	—
Sep 11, 2024144	144	Notice of proposed sale (Form 144)	—
Sep 10, 2024144	144	Notice of proposed sale (Form 144)	—
Aug 27, 20244	4	Insider transaction (Form 4)	Aug 27, 2024
Aug 21, 20244	4	Insider transaction (Form 4)	Aug 20, 2024
Aug 21, 2024144	144	Notice of proposed sale (Form 144)	—
Aug 20, 2024144	144	Notice of proposed sale (Form 144)	—

The newest 25 of 88 shown; the full year is on EDGAR.

2023 · 72 filings — 39 × 4, 21 × 144, 5 × SC 13G/A and 5 other forms

Counted, not listed; the year is on EDGAR.

2022 · 36 filings — 22 × 4, 4 × SC 13G/A, 3 × 3 and 3 other forms

Counted, not listed; the year is on EDGAR.

2021 · 49 filings — 43 × 4, 4 × SC 13G/A, 2 × S-8

Counted, not listed; the year is on EDGAR.

2020 · 57 filings — 46 × 4, 5 × SC 13G/A, 3 × 3 and 2 other forms

Counted, not listed; the year is on EDGAR.

2019 · 42 filings — 31 × 4, 4 × SC 13G/A, 3 × SC 13D/A and 3 other forms

Counted, not listed; the year is on EDGAR.

2018 · 43 filings — 30 × 4, 6 × SC 13G/A, 3 × 3 and 3 other forms

Counted, not listed; the year is on EDGAR.

2017 · 35 filings — 25 × 4, 4 × SC 13G/A, 2 × 424B5 and 3 other forms

Counted, not listed; the year is on EDGAR.

2016 · 36 filings — 24 × 4, 4 × SC 13G/A, 2 × 3 and 6 other forms

Counted, not listed; the year is on EDGAR.

2015 · 39 filings — 22 × 4, 5 × 3, 4 × SC 13G/A and 5 other forms

Counted, not listed; the year is on EDGAR.

2014 · 30 filings — 21 × 4, 3 × SC 13G, 2 × 424B5 and 4 other forms

Counted, not listed; the year is on EDGAR.

2013 · 34 filings — 26 × 4, 2 × 3, 1 × CORRESP and 5 other forms

Counted, not listed; the year is on EDGAR.

2012 · 35 filings — 23 × 4, 3 × CORRESP, 3 × UPLOAD and 4 other forms

Counted, not listed; the year is on EDGAR.

2011 · 30 filings — 22 × 4, 2 × 3, 2 × UPLOAD and 4 other forms

Counted, not listed; the year is on EDGAR.

2010 · 19 filings — 12 × 4, 2 × 3, 2 × 424B5 and 3 other forms

Counted, not listed; the year is on EDGAR.

2009 · 19 filings — 12 × 4, 2 × 3, 2 × 424B5 and 3 other forms

Counted, not listed; the year is on EDGAR.

2008 · 45 filings — 29 × 4, 3 × EFFECT, 3 × POS AM and 7 other forms

Counted, not listed; the year is on EDGAR.

2007 · 112 filings — 94 × 4, 6 × 4/A, 2 × 3 and 10 other forms

Counted, not listed; the year is on EDGAR.

2006 · 28 filings — 12 × 4, 4 × 3, 3 × SC 13G/A and 7 other forms

Counted, not listed; the year is on EDGAR.

2005 · 47 filings — 11 × 4, 9 × 5, 7 × 3/A and 12 other forms

Counted, not listed; the year is on EDGAR.

2004 · 46 filings — 11 × 3, 8 × 4, 5 × SC 13G/A and 14 other forms

Counted, not listed; the year is on EDGAR.

2003 · 9 filings — 3 × 10QSB, 3 × SC 13G, 1 × 10KSB and 2 other forms

Counted, not listed; the year is on EDGAR.

2002 · 11 filings — 3 × 10QSB, 3 × 3, 2 × SB-2/A and 3 other forms

Counted, not listed; the year is on EDGAR.

2001 · 3 filings — 2 × SB-2/A, 1 × SB-2

Counted, not listed; the year is on EDGAR.

About this data

Halozyme Therapeutics Inc. (HALO) has 1,514 filings on EDGAR going back to 2001: 20 annual reports, 63 quarterly reports and 296 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 17, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 30, 2026, covered directors or officers; compensation. Over the last 13 months insiders sold $36.0M in 32 sales and bought nothing on the open market; 125 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Halozyme Therapeutics Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read HALO's latest 10-K?: HALO's latest annual report, a 10-K, was filed on Feb 17, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did HALO last file an 8-K?: On Sep 30, 2026: directors or officers; compensation. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 6, 2026.
Are HALO insiders buying or selling?: Over the last 13 months insiders sold $36.0M in 32 sales and bought nothing on the open market; 125 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Posard Matthew L. (Director) sold 5,230 shares on Oct 1, 2026 for $568K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has HALO made?: 1,514 filings are on EDGAR under the registrant records that have been Halozyme Therapeutics Inc., going back to 2001; 847 of them are insider ownership forms (Forms 3, 4, 5 and 144).

HALO SEC filings (2026)

What happened, last 12 months#

October 2026

September 2026

August 2026

July 2026

June 2026

May 2026

April 2026

March 2026

February 2026

January 2026

December 2025

November 2025

October 2025

Insider transactions#

Reports and proxy statements#

Insider, ownership and other filings#

About this data

FAQ#